Upload

Loading...

'Quadrapeutics' works in preclinical study of hard-to-treat tumors

32,826

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jun 2, 2014

A Rice University-led study in the June 1, 2014 issue of Nature Medicine reports the first preclinical tests for a novel anti-cancer technology called "quadrapeutics" that converts current clinical treatments to instantaneously detect and kill only cancer cells. Quadrapeutics combines clinically available drugs, colloidal gold, pulsed lasers and radiation in a novel and safe micro-treatment that improved standard therapy by 17-fold against aggressive, drug-resistant tumors.

  • Category

  • License

    • Standard YouTube License

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up Next


Sign in to add this to Watch Later

Add to